PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Brigham and Women\'s Hospital, Harvard Medical School, Boston, Massachusetts, USA (B.B.).\', \'University of Washington, Seattle, Washington, USA (D.A.G.).\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.7326/J21-0020
?:doi
?:hasPublicationType
?:journal
  • Annals of internal medicine
is ?:pmid of
?:pmid
?:pmid
  • 35099997
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.466
?:rankingScore_hIndex
  • 349
is ?:relation_isRelatedTo_publication of
?:title
  • In patients hospitalized with COVID-19, therapeutic- vs. prophylactic-dose heparin did not reduce a composite outcome at 28 d.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all